CVR: 39181274
Secondary names: PLMS ApS (Private Label Manufactoring Service), Kurm Health & Beauty ApS
DKK -2,598,150
Gross profit
Net result: DKK -1,978,646
Fitzrovia ApS
CVR · view ownership and management
Owner registered: Fitzrovia ApS
CVR · 14/04/2023
View the full event history
Kurm Pharma ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2017. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The management consists of Jacob Gjelstrup and Jesper Gjelstrup. The company is owned by Fitzrovia ApS. In 2025, the company reported a gross profit of DKK -2,598,150 and a net result of DKK -1,978,646 compared with DKK 602,189 the year before. Equity in the 2025 report amounted to DKK 1,813,033.
Selskabets formål er at drive virksomhed med salg af kosttilskud og kosmetiske produkter på det internationale marked.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -2.6 mio. | -2 mio. | 5.1 mio. | 1.8 mio. | 0 | |
| 202401/01/2024 – 31/12/2024 | 331 t. | 602 t. | 6.9 mio. | 4.1 mio. | - | |
| 202301/01/2023 – 31/12/2023 | 91 t. | 242 t. | 4.8 mio. | 3.5 mio. | - | |
| 202201/01/2022 – 31/12/2022 | 459 t. | 333 t. | 3.7 mio. | 3.2 mio. | - | |
| 202101/01/2021 – 31/12/2021 | 2.6 mio. | 2 mio. | 4.8 mio. | 3.1 mio. | - | |
| 202001/01/2020 – 31/12/2020 | 947 t. | 705 t. | 4.3 mio. | 969 t. | - | |
| 201901/01/2019 – 31/12/2019 | 667 t. | 506 t. | 3.9 mio. | 904 t. | - | |
| 201818/12/2017 – 31/12/2018 | 494 t. | 348 t. | 3.1 mio. | 398 t. | - |
Compared to 86 companies in Fremstilling af parfume, hårshampoo, tandpasta mv.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningKurm Pharma ApS was founded on 18 December 2017.
Kurm Pharma ApS is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv. (industry code 204200).
Kurm Pharma ApS is owned by Fitzrovia ApS.
In 2025, Kurm Pharma ApS reported a gross profit of DKK -2,598,150.
The management of Kurm Pharma ApS consists of Jacob Gjelstrup and Jesper Gjelstrup.
Kurm Pharma ApS is located at Ferrarivej 12, 7100 Vejle.
Claim this page to add your logo and social links. Free to get started.
Kurm Pharma ApS has published its annual report for 2025. Gross profit came to DKK -2,598,150, and the net result was DKK -1,978,646.
Kurm Pharma ApS has published its annual report for 2024. Gross profit came to DKK 331,133, and the net result was DKK 602,189.
As of January 20, 2025, Allan Christensen has joined the board of directors of Kurm Pharma ApS.
As of August 6, 2024, Steen Nordstrøm has joined the board of directors of Kurm Pharma ApS.
As of August 5, 2024, Steen Nordstrøm has left the board of directors of Kurm Pharma ApS.
As of July 9, 2024, Peter Vammen has left the board of directors of Kurm Pharma ApS.
Kurm Pharma ApS has published its annual report for 2023. Gross profit came to DKK 91,002, and the net result was DKK 241,730.
As of October 1, 2023, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Kurm Pharma ApS.
As of October 1, 2023, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has stepped down as auditor of Kurm Pharma ApS.
As of April 14, 2023, Fitzrovia ApS is registered as an owner of Kurm Pharma ApS with an ownership share of 100%.
Kurm Pharma ApS has published its annual report for 2022. Gross profit came to DKK 459,138, and the net result was DKK 332,526.
Kurm Pharma ApS has published its annual report for 2021. Gross profit came to DKK 2,610,379, and the net result was DKK 1,996,154.
Kurm Pharma ApS has published its annual report for 2020. Gross profit came to DKK 947,022, and the net result was DKK 704,980.
As of June 17, 2020, Johannes Gjelstrup has left the board of directors of Kurm Pharma ApS.
Kurm Pharma ApS has published its annual report for 2019. Gross profit came to DKK 666,835, and the net result was DKK 506,343.
Kurm Pharma ApS has published its annual report for 2018. Gross profit came to DKK 494,249, and the net result was DKK 347,758.
As of January 11, 2018, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has been appointed auditor of Kurm Pharma ApS.
As of January 11, 2018, KVIST & JENSEN, GRENAA STATSAUTORISEREDE REVISORER A/S has stepped down as auditor of Kurm Pharma ApS.
As of January 5, 2018, Jacob Gjelstrup has joined the board of directors of Kurm Pharma ApS.
As of January 5, 2018, Jesper Gjelstrup has joined the board of directors of Kurm Pharma ApS.
As of January 5, 2018, Johannes Gjelstrup has joined the board of directors of Kurm Pharma ApS.
As of January 5, 2018, Peter Vammen has joined the board of directors of Kurm Pharma ApS.
As of January 5, 2018, Steen Nordstrøm has joined the board of directors of Kurm Pharma ApS.
As of December 18, 2017, KVIST & JENSEN, GRENAA STATSAUTORISEREDE REVISORER A/S has been appointed auditor of Kurm Pharma ApS.
As of December 18, 2017, Jacob Gjelstrup is registered as director of Kurm Pharma ApS.
As of December 18, 2017, Jesper Gjelstrup is registered as director of Kurm Pharma ApS.
Kurm Pharma ApS was founded on December 18, 2017.
Companies in the same industry and area
CVR 26638445
CVR 41796979
CVR 36393440
CVR 43995022
CVR 44884968
